Restless Leg Syndrome | Restless Leg Syndrome and Severe Preeclampsia
Restless Leg Syndrome research study
What is the primary objective of this study?
Restless Leg Syndrome is a common but not well recognized central nervous system disorder. It
is more prevalent during pregnancy and, if present before pregnancy, can develop an
exacerbation of symptoms. In some of the hypothesis trying to explain this syndrome, the
physiopathology can also explain hypertensive disorders of pregnancy. So far, no study has
been done trying to link both disorders.
Who is eligible to participate?
- Gestational age between 24-34 weeks
- Severe preeclampsia
- Neurological disorders (central nervous system)
Which medical condition, disease, disorder, syndrome, illness, or injury is researched?
Restless Leg Syndrome
Interventions can include giving participants drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available or noninvasive approaches such as surveys, education, and interviews.
Research studies and clinical trials typically have two or more research arms. An arm is a group of people who receive the same treatment in the study.
CasesPatients with Severe preeclampsia
ControlPatients with normal pregnancies at term
Start Date: August 1, 2017
Completed Date: December 15, 2017
Primary Outcome: Restless Leg Syndrome
Study sponsors, principal investigator, and references
Principal Investigator: Osvaldo A Reyes, MD
Lead Sponsor: Saint Thomas Hospital, Panama